Wells Fargo & Company: Form 10-Q for the period ended Sep 30, 2025
Filed with the SEC on Oct 31, 2025 and accepted by EDGAR at Oct 31, 2025, 16:23 ET.
Management's discussion and analysis
As filed, 1,565 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Unregistered Issuance of Equity Securities
On August 13, 2025, and August 14, 2025, the Company issued an aggregate of 411,536 shares of common stock to plaintiffs’ counsel as payment in connection with the settlement of the Himstreet v. Scharf et al. shareholder derivative action previously disclosed in the Company’s Current Report on Form 8-K filed April 30, 2025. The shares were issued in reliance on the exemption from registration under Section 3(a)(10) of the Securities Act of 1933, as amended.
Repurchases of Equity Securities
The following table shows Company repurchases of its common stock for each calendar month in the quarter ended September 30, 2025.
| Calendar month | Total number of shares repurchased (1) | Weighted average price paid per share | Approximate dollar value of shares that may yet be repurchased under the authorization (in millions) |
|---|---|---|---|
| July | 28,000,000 | $81.76 | $38,468 |
| August | 29,726,893 | 79.05 | 36,118 |
| September | 16,832,532 | 80.84 | 34,758 |
| Total | 74,559,425 |
(1) A portion of the shares repurchased in July 2025 were under an authorization covering up to $30 billion of common stock approved by the Board of Directors (Board) and publicly announced by the Company on July 25, 2023. All remaining shares were repurchased under an authorization covering up to an additional $40 billion of common stock approved by the Board and publicly announced by the Company on April 29, 2025. Unless modified or revoked by the Board, these authorizations do not expire.
Risk factors
As filed, 179 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Information in response to this item can be found under the “Financial Review – Risk Factors” section in this Report which information is incorporated by reference into this item.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-07-01 to 2025-09-30 | $21.44bn | us-gaap:RevenuesNetOfInterestExpense |
| Revenue | 9 months2025-01-01 to 2025-09-30 | $62.41bn | us-gaap:RevenuesNetOfInterestExpense |
| Income tax | 3 months2025-07-01 to 2025-09-30 | $1.30bn | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2025-01-01 to 2025-09-30 | $2.74bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-07-01 to 2025-09-30 | $5.59bn | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-01-01 to 2025-09-30 | $15.98bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-07-01 to 2025-09-30 | $1.66 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-01-01 to 2025-09-30 | $4.64 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-07-01 to 2025-09-30 | $1.68 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-01-01 to 2025-09-30 | $4.69 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-07-01 to 2025-09-30 | 3,223,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-01-01 to 2025-09-30 | 3,270,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-01-01 to 2025-09-30 | −$23.12bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 9 months2025-01-01 to 2025-09-30 | $4.04bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2025-01-01 to 2025-09-30 | $12.52bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Total assets | At period end2025-09-30 | $2.06tn | us-gaap:Assets |
| Total liabilities | At period end2025-09-30 | $1.88tn | us-gaap:Liabilities |
| Long-term debt | At period end2025-09-30 | $177.77bn | us-gaap:LongTermDebt |
| Short-term borrowings | At period end2025-09-30 | $230.65bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2025-09-30 | $181.15bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000072971-25-000253. Last ingested by Listed: Nov 10, 2026, 21:52 ET. Listed shows no prices and gives no investment advice.